Rick Wise
Stock Analyst at Stifel
(4.08)
# 468
Out of 5,182 analysts
271
Total ratings
60%
Success rate
9.16%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $90 → $85 | $59.95 | +41.78% | 20 | Apr 21, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $120 | $92.80 | +29.31% | 22 | Apr 17, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $220 → $250 | $225.34 | +10.94% | 9 | Apr 15, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $70.48 | +39.05% | 4 | Feb 5, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $83.46 | +31.80% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $45.23 | +1.70% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $1.92 | +56.25% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $69.78 | +50.47% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $4.40 | +82.03% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $63.41 | +10.39% | 7 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $210 → $215 | $150.22 | +43.12% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $31.73 | +26.06% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $15.82 | +26.42% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $82.92 | +26.63% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $37.03 | +24.22% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $92.59 | +27.44% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $18.49 | +35.21% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.28 | +290.63% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $37.87 | +45.23% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $22.23 | +25.96% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $29.04 | +65.29% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $329.01 | +33.73% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $470.99 | +29.51% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $178.66 | +6.35% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.79 | +76.80% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $114.52 | -34.51% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.82 | +21.09% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $24.62 | +1.54% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $65.09 | +72.07% | 5 | Oct 2, 2020 |
Boston Scientific
Apr 21, 2026
Maintains: Buy
Price Target: $90 → $85
Current: $59.95
Upside: +41.78%
Abbott Laboratories
Apr 17, 2026
Maintains: Buy
Price Target: $145 → $120
Current: $92.80
Upside: +29.31%
Johnson & Johnson
Apr 15, 2026
Maintains: Hold
Price Target: $220 → $250
Current: $225.34
Upside: +10.94%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $70.48
Upside: +39.05%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $83.46
Upside: +31.80%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $45.23
Upside: +1.70%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $1.92
Upside: +56.25%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $69.78
Upside: +50.47%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $4.40
Upside: +82.03%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $63.41
Upside: +10.39%
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $150.22
Upside: +43.12%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $31.73
Upside: +26.06%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $15.82
Upside: +26.42%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $82.92
Upside: +26.63%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $37.03
Upside: +24.22%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $92.59
Upside: +27.44%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $18.49
Upside: +35.21%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.28
Upside: +290.63%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $37.87
Upside: +45.23%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.23
Upside: +25.96%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $29.04
Upside: +65.29%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $329.01
Upside: +33.73%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $470.99
Upside: +29.51%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $178.66
Upside: +6.35%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.79
Upside: +76.80%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $114.52
Upside: -34.51%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.82
Upside: +21.09%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $24.62
Upside: +1.54%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $65.09
Upside: +72.07%